Sanofi and Bristol-Myers Squibb collect damages in Plavix patent litigation with Apotex
8 February 2012 | By Bristol-Myers Squibb Company
Apotex has made payment to Sanofi & Bristol-Myers Squibb...
List view / Grid view
8 February 2012 | By Bristol-Myers Squibb Company
Apotex has made payment to Sanofi & Bristol-Myers Squibb...
30 January 2012 | By Sanofi
These commitments are a key part of the "Uniting to Combat Neglected Tropical Diseases" partnership...
24 January 2012 | By Sanofi
The FDA has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta)...
18 January 2012 | By Sanofi
Sanofi & Genzyme announced that the EMA has approved its manufacturing plant in Framingham....
10 January 2012 | By Sanofi
Sanofi is co-investing in Warp Drive Bio, an innovative start-up biotechnology company...
6 December 2011 | By Sanofi
Data from phase III GetGoal Duo 1 study...
29 November 2011 | By Sanofi
Sanofi organizes the 10th Edition of the Pan-African Conference against Malaria with representatives of 34 African Countries...
14 November 2011 | By Sanofi
The Phase lll CARE-MS ll trial met both of its co-primary endpoints...
10 November 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program...
1 November 2011 | By College Hill
Sanofi is expected to take the top spot amongst the world’s pharmaceuticals manufacturers in 2012...
24 October 2011 | By Sanofi
Sanofi announced the appointment of David Meeker as Chief Executive Officer of Genzyme, effective November 1, 2011...
22 October 2011 | By Sanofi
New results from the CARE-MS I trial...
12 September 2011 | By Sanofi
New phase III data from GetGoal-F1 study...
28 July 2011 | By Sanofi
Sanofi has appointed Dr. David-Alexandre Gros as Chief Strategy Officer, effective September 1, 2011...
22 July 2011 | By Sanofi
Sanofi is pleased to announce the appointment of Greg Irace, to the newly created role of Senior Vice President, Global Services...